America's Poison Centers
US$ 21.32
glp 1 drugs and pcos Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy GLP-1 for PCOS: Is It
Description
2021 May 3;5(Suppl 1):A7
GLP-1RAs induce weight loss by reducing food intake (7174)
Lancet 2018;392:151929.PubMed 70
Several landmark studies have shaped current understanding
It is a recombinant form of the peptide exendin-4, which is a GLP-1 receptor agonist with a 53% similarity to the gastrointestinal hormone GLP-1 and it is resistant to DPP-4 inactivation with a 140-minute half-life after subcutaneous administration allowing therapy by a twice daily administration [36]
China 17.3.9.2
